A. K. van Engen - Concepedia

Author

A. K. van Engen

Also Known As

A. K. Van Engen, A. K. van Engen, A.K. van Engen

Publications

157

Citations

H-Index

Concepts

All Affiliations

A. K. van Engen is an author at Astellas Pharma (United Kingdom).

A. K. van Engen

Publications

153

Citations

H-Index

Page 1

	Year	Citations
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection Dilip Nathwani, Oliver A. Cornely, A. K. van Engen, Journal of Antimicrobial Chemotherapy	2014	85
Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany Oliver A. Cornely, M. Sidhu, Isaac Odeyemi, Current Medical Research and Opinion	2008	41
Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic <i>Candida</i> infections in the UK M. Sidhu, A. K. van Engen, J. Kleintjens, Current Medical Research and Opinion	2009	27

Page 1